PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy

por Huang, Yi-Teng, Li, Fei-Fei, Ke, Chen, Li, Zhou, Li, Zong-Tai, Zou, Xiao-Fang, Zheng, Xiao-Xuan, Chen, Yu-Ping, Zhang, Hao
Publicado 2013